Education
About Us
Working with TipRanks
Follow Us
CVRx (CVRX)
NASDAQ:CVRX
CVRX Stock Chart & Stats
Day’s Range― - ―
52-Week Range$4.30 - $18.55
Previous CloseN/A
Volume20.10K
Average Volume (3M)244.85K
Market Cap
$207.91M
Enterprise Value$108.82M
Total Cash (Recent Filing)$95.03M
Total Debt (Recent Filing)$50.54M
Price to Earnings (P/E)―
Beta1.32
Next Earnings
Nov 04, 2025EPS Estimate
-0.5Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.57
Shares Outstanding26,151,724
10 Day Avg. Volume120,471
30 Day Avg. Volume244,854
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap0.52
Enterprise Value/Revenue1.99
Enterprise Value/Gross Profit2.37
Enterprise Value/Ebitda-2.36
Forecast
1Y Price Target
$10.70Price Target Upside35.79% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
Bulls Say, Bears Say
Bulls Say
Management And OperationsManagement is optimistic about the quality of new hires, many of whom have experience in market development for other heart failure devices.
Reimbursement StrategyCVRX will benefit from the removal of automatic denials as its Category I code goes live.
Sales PerformanceSales came in 2% ahead of the Street, benefiting from some early rewards of sales force stabilization and headcount investments.
Bears Say
Guidance And ExpectationsThe high end of guidance was lowered by one million dollars, which represents only 16 units, and the lowering of the top end of the guidance range seems to cap upside potential.
Salesforce DisruptionQ1 miss was attributed to the company being unable to manage the disruption from the deeper-than-expected salesforce changes.
Valuation ExpectationsAt current valuation, status quo is baked into investor expectations, and therefore no significant reaction in the stock price is expected post this news.
CVRx News
CVRX FAQ
What was CVRx’s price range in the past 12 months?
CVRx lowest stock price was $4.30 and its highest was $18.55 in the past 12 months.
What is CVRx’s market cap?
CVRx’s market cap is $207.91M.
When is CVRx’s upcoming earnings report date?
CVRx’s upcoming earnings report date is Nov 04, 2025 which is in 54 days.
How were CVRx’s earnings last quarter?
CVRx released its earnings results on Aug 04, 2025. The company reported -$0.57 earnings per share for the quarter, missing the consensus estimate of -$0.52 by -$0.05.
Is CVRx overvalued?
According to Wall Street analysts CVRx’s price is currently Undervalued.
Does CVRx pay dividends?
CVRx does not currently pay dividends.
What is CVRx’s EPS estimate?
CVRx’s EPS estimate is -0.5.
How many shares outstanding does CVRx have?
CVRx has 26,151,724 shares outstanding.
What happened to CVRx’s price movement after its last earnings report?
CVRx reported an EPS of -$0.57 in its last earnings report, missing expectations of -$0.52. Following the earnings report the stock price went down -9.934%.
Which hedge fund is a major shareholder of CVRx?
Currently, no hedge funds are holding shares in CVRX
CVRx Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$10.70 (35.79% Upside)
$10.70 (35.79% Upside)
Blogger Sentiment
Bullish
CVRX Sentiment 100%
Sector Average 71%
Sector Average 71%
Crowd Wisdom
Very Positive
Last 7 Days ▼ 1.0%
Last 30 Days ▲ 5.7%
Last 30 Days ▲ 5.7%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
1.25%
12-Months-Change
Fundamentals
Return on Equity
-92.33%
Trailing 12-Months
Asset Growth
24.57%
Trailing 12-Months
Company Description
CVRx
CVRx, Inc. is a medical device company that operates within the healthcare sector, focusing on the development and commercialization of innovative neuromodulation solutions. Its core product, the Barostim System, is designed to improve the quality of life for patients with cardiovascular diseases such as heart failure and hypertension by using the body's natural feedback mechanisms.
CVRX Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presents a generally positive outlook with significant revenue growth and expansion in implanting centers and sales territories. Improvements in reimbursement strategies and stable gross margins further contribute to the positive sentiment. However, challenges such as increased net loss, higher SG&A expenses, and rising interest expenses present areas of concern.View all CVRX earnings summariesCVRX Stock 12 Month Forecast
Average Price Target
$10.70
▲(35.79% Upside)
Technical Analysis
Ownership Overview
11.58% Insiders
7.09% Mutual Funds
30.46% Other Institutional Investors
44.83% Public Companies and
Individual Investors